Northwest Biotherapeutics Inc (NWBO)
0.4601
-0.01
(-2.54%)
USD |
OTCM |
Apr 24, 16:00
Northwest Biotherapeutics Total Liabilities (Quarterly): 93.64M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 93.64M |
| September 30, 2023 | 96.61M |
| June 30, 2023 | 89.47M |
| March 31, 2023 | 88.85M |
| December 31, 2022 | 159.43M |
| September 30, 2022 | 139.95M |
| June 30, 2022 | 119.19M |
| March 31, 2022 | 151.18M |
| December 31, 2021 | 164.15M |
| September 30, 2021 | 329.95M |
| June 30, 2021 | 378.61M |
| March 31, 2021 | 385.66M |
| December 31, 2020 | 395.85M |
| September 30, 2020 | 239.64M |
| June 30, 2020 | 96.22M |
| March 31, 2020 | 44.18M |
| December 31, 2019 | 55.70M |
| September 30, 2019 | 64.68M |
| June 30, 2019 | 67.71M |
| March 31, 2019 | 82.97M |
| December 31, 2018 | 71.83M |
| September 30, 2018 | 93.47M |
| June 30, 2018 | 112.27M |
| March 31, 2018 | 112.80M |
| December 31, 2017 | 96.20M |
| Date | Value |
|---|---|
| September 30, 2017 | 92.58M |
| June 30, 2017 | 82.63M |
| March 31, 2017 | 84.95M |
| December 31, 2016 | 79.40M |
| September 30, 2016 | 53.96M |
| June 30, 2016 | 70.58M |
| March 31, 2016 | 68.42M |
| December 31, 2015 | 75.47M |
| September 30, 2015 | 109.00M |
| June 30, 2015 | 140.42M |
| March 31, 2015 | 120.11M |
| December 31, 2014 | 91.48M |
| September 30, 2014 | 60.61M |
| June 30, 2014 | 42.45M |
| March 31, 2014 | 43.57M |
| December 31, 2013 | 28.60M |
| September 30, 2013 | 32.72M |
| June 30, 2013 | 29.69M |
| March 31, 2013 | 28.57M |
| December 31, 2012 | 23.64M |
| September 30, 2012 | 38.53M |
| June 30, 2012 | 31.68M |
| March 31, 2012 | 25.04M |
| December 31, 2011 | 52.38M |
| September 30, 2011 | 48.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
44.18M
Minimum
Mar 2020
395.85M
Maximum
Dec 2020
166.35M
Average
119.19M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.86M |
| Shareholders Equity (Quarterly) | -65.77M |
| Debt to Equity Ratio | -0.6202 |
| Current Ratio | 0.0913 |
| Net Debt Paydown Yield | -0.36% |